Jubilant Ingrevia reported a 7% year-on-year growth in Q2 FY26, driven by strong volume growth. The Specialty Chemicals segment continues to be a key growth driver. EBITDA grew by 8% year-on-year, while profit after tax increased by 18%. The company anticipates continued growth momentum in Specialty Chemicals and Nutrition businesses, with a partial recovery expected in the Acetyl portfolio. The company is on track to start serving its major CDMO order in early 2026.
Financial Highlights
Jubilant Ingrevia announced its financial results for Q2 FY26, showcasing robust performance. Key highlights include:
- Overall revenue reached INR 1,121 crore, the highest in the last 10 quarters.
- Volume growth of approximately 18% despite macroeconomic headwinds.
- EBITDA for the quarter stood at INR 146 crore, an 8% year-on-year increase.
- Profit after tax (PAT) increased by 18% year-on-year to INR 70 crore.
Segment Performance
The Specialty Chemicals segment delivered a 12% year-on-year revenue growth, with EBITDA growing by 50% year-on-year to INR 125 crore. The Nutrition & Health Solutions business saw volume growth but a marginal revenue decline of 1% year-on-year due to pricing pressure. The Chemical Intermediates segment delivered 20% sequential revenue growth and 6% year-on-year growth.
Strategic Initiatives and Outlook
The company has expanded its opportunity funnel to over 100 active opportunities, up from 70 in Q1. It expects to launch 18 new products in FY26. Jubilant Ingrevia also plans to invest approximately INR 600 crore in FY26, with a focus on the CDMO Agro project and a new multipurpose plant at Gajraula. Renewable power share has increased to 28%.
CDMO Business Expansion
Jubilant Ingrevia is on track to start serving its major CDMO order in early 2026. The company has added 10 new molecules to its CDMO and Fine Chemical portfolio, expected to contribute almost INR 1,200 crore of peak annual revenues in coming years. The company is also planning for a state-of-the-art Semi-conductor R&D facility in Greater Noida.
Source: BSE
